Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients

References

• Zavazava N. Soluble HLA class I molecules: biological significance and clinical implications. Mol Med Today. 1998;4:116–121.
   PubMedGoogle Scholar
• Gugenheim J, Amorosa L, Gigou M, et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation. 1990;50:309–313.
   PubMed Web of Science ®Google Scholar
• Taner T, Park WD, Stegall MD. Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation. Kidney Int. 2017;91:1193–1202.
   PubMed Web of Science ®Google Scholar
• Taner T, Gustafson MP, Hansen MJ, et al. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year. Kidney Int. 2018;93:1465–1474.
   PubMed Web of Science ®Google Scholar
• O’Leary JG, Gebel HM, Ruiz R, et al. Class II alloantibody and mortality in simultaneous liver-kidney transplantation. Am J Transplant. 2013;13:954–960.
   PubMed Web of Science ®Google Scholar
• Yazawa M, Cseprekal O, Helmick AR, et al. Association between post-transplant donor specific antibodies and recipient outcomes in simultaneous liver-kidney transplant recipients: single center, cohort study. Transpl Int. 2019; doi:https://doi.org/10.1111/tri.13543. [Epub ahead of print] PubMed PMID: 31647143.
   Google Scholar
• Taner T, Gandhi MJ, Sanderson SO, et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant. 2012;12:1504–1510.
   PubMed Web of Science ®Google Scholar
• Dar W, Agarwal A, Watkins C, et al. Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. Am J Transplant. 2011;11:841–847.
   PubMed Web of Science ®Google Scholar
• Paterno F, Girnita A, Brailey P, et al. Successful simultaneous liver-kidney transplantation in the presence of multiple high-titered Class I and II antidonor HLA antibodies. Transplant Direct. 2016;2:e121.
   PubMed Web of Science ®Google Scholar
• Jucaud V, Shaked A, DesMarais M, et al. Prevalence and impact of de novo donor-specific antibodies during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients. Hepatology (Baltimore, MD). 2019;69:1273–1286.
   PubMed Web of Science ®Google Scholar
• O’Sullivan K, Martensson J, Robbins R, et al. Epidemiology of long-stay patients in a university teaching hospital. Intern Med J. 2017;47:513–521.
   PubMed Web of Science ®Google Scholar
• McAdams-DeMarco MA, King EA, Luo X, et al. Frailty, length of stay, and mortality in kidney transplant recipients: a national registry and prospective cohort study. Ann Surg. 2017;266:1084–1090.
   PubMed Web of Science ®Google Scholar
• Brasel KJ, Lim HJ, Nirula R, et al. Length of stay: an appropriate quality measure? Arch Surg. 2007;142:461–465. discussion 465–466.
   PubMedGoogle Scholar
• Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499–1507.
   PubMed Web of Science ®Google Scholar
• Micek S, Johnson MT, Reichley R, et al. An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect Dis. 2012;12:56.
   PubMed Web of Science ®Google Scholar
• Baek H, Cho M, Kim S, et al. Analysis of length of hospital stay using electronic health records: a statistical and data mining approach. PLoS One. 2018;13:e0195901.
   PubMed Web of Science ®Google Scholar
• Arefian H, Hagel S, Heublein S, et al. Extra length of stay and costs because of health care-associated infections at a German university hospital. Am J Infect Control. 2016;44:160–166.
   PubMed Web of Science ®Google Scholar
• Singh N, Paterson DL, Gayowski T, et al. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl. 2000;6:54–61.
   PubMed Web of Science ®Google Scholar
• Ruiz J, Dugan A, Davenport DL, et al. Blood transfusion is a critical determinant of resource utilization and total hospital cost in liver transplantation. Clin Transplant. 2018;32:e13164.
   Web of Science ®Google Scholar
• Nedelcu E, Wright MF, Karp S, et al. Quality improvement in transfusion practice of orthotopic liver transplantation reduces blood utilization, length of hospital stay, and cost. Am J Clin Pathol. 2019;151:395–402.
   PubMed Web of Science ®Google Scholar
• Zhang R. Donor-specific antibodies in kidney transplant recipients. Clin J Am Soc Nephrol. 2018;13:182–192.
   PubMed Web of Science ®Google Scholar
• Knoll GA, MacDonald I, Khan A, et al. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol. 2003;14:2381–2386.
   PubMed Web of Science ®Google Scholar
• Croome KP, Hernandez-Alejandro R, Chandok N. Early allograft dysfunction is associated with excess resource utilization after liver transplantation. Transplant Proc. 2013;45:259–264.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• OPTN/UNOS Kidney Transplantation Committee. OPTN/UNOS public comment proposal. Simultaneous liver kidney (SLK) allocation policy. Available from: https://optn.transplant.hrsa.gov/media/1192/0815-1112_SLK_Allocation.pdf
   Google Scholar
• Health Resources and Services Administration USDoHHS. The Ethics of Organ Donation from Condemned Prisoners. Available from: https://optn.transplant.hrsa.gov/resources/ethics/the-ethics-of-organ-donation-from-condemned-prisoners/
   Google Scholar
• Mone T, Heldens J, Niemann CU. Deceased organ donor research: the last research frontier? Liver Transpl. 2013;19:118–121.
   PubMed Web of Science ®Google Scholar
• Yoo MC, Vanatta JM, Modanlou KA, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction in 500 consecutive patients. Transplantation. 2015;99:1231–1235.
   PubMed Web of Science ®Google Scholar
• Catalano G, Tandoi F, Mazza E, et al. Simultaneous liver-kidney transplantation in adults: a single-center experience comparing results with isolated liver transplantation. Transplant Proc. 2015;47:2156–2158.
   PubMed Web of Science ®Google Scholar
• Baccaro ME, Pepin MN, Guevara M, et al. Combined liver-kidney transplantation in patients with cirrhosis and chronic kidney disease. Nephrol Dial Transplant. 2010;25:2356–2363.
   PubMed Web of Science ®Google Scholar
• Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11:2279–2296.
   PubMed Web of Science ®Google Scholar
• Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant. 2007;7:1702–1709.
   PubMed Web of Science ®Google Scholar
• Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant. 2008;8:2243–2251.
   PubMed Web of Science ®Google Scholar
• Hussain SM, Sureshkumar KK. Refining the role of simultaneous liver kidney transplantation. J Clin Transl Hepatol. 2018;6:289–295.
   PubMed Web of Science ®Google Scholar
• Locke JE, Warren DS, Singer AL, et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation. 2008;85:935–942.
   PubMed Web of Science ®Google Scholar
• Tanriover B, MacConmara MP, Parekh J, et al. Simultaneous liver kidney transplantation in liver transplant candidates with renal dysfunction: importance of creatinine levels, dialysis, and organ quality in survival. Kidney Int Rep. 2016;1:221–229.
   PubMed Web of Science ®Google Scholar
• Triulzi DJ. Specialized transfusion support for solid organ transplantation. Curr Opin Hematol. 2002;9:527–532.
   PubMed Web of Science ®Google Scholar
• Witczak BJ, Leivestad T, Line PD, et al. Experience from an active preemptive kidney transplantation program–809 cases revisited. Transplantation. 2009;88:672–677.
   PubMed Web of Science ®Google Scholar
• Haller MC, Kammer M, Oberbauer R. Dialysis vintage and outcomes in renal transplantation. Nephrol Dial Transplant. 2019;34:555–560.
   PubMed Web of Science ®Google Scholar
• Fidler S, Swaminathan R, Lim W, et al. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss. Transpl Immunol. 2013;29:22–27.
   PubMed Web of Science ®Google Scholar